| Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing S Melo, A Villanueva, C Moutinho, V Davalos, R Spizzo, C Ivan, S Rossi, ... Proceedings of the National Academy of Sciences 108 (11), 4394-4399, 2011 | 267 | 2011 |
| Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes C Chong, M Müller, HS Pak, D Harnett, F Huber, D Grun, M Leleu, ... Nature communications 11 (1), 1293, 2020 | 234 | 2020 |
| Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis M Rodriguez-Paredes, A Martinez de Paz, L Simo-Riudalbas, S Sayols, ... Oncogene 33 (21), 2807-2813, 2014 | 180 | 2014 |
| Targeting the histone orthography of cancer: drugs for writers, erasers and readers L Simó‐Riudalbas, M Esteller British journal of pharmacology 172 (11), 2716-2732, 2015 | 128 | 2015 |
| Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis C Anadón, S Guil, L Simó-Riudalbas, C Moutinho, F Setien, ... Oncogene 35 (33), 4407-4413, 2016 | 89 | 2016 |
| Whole-genome bisulfite DNA sequencing of a DNMT3B mutant patient H Heyn, E Vidal, S Sayols, JV Sanchez-Mut, S Moran, I Medina, ... Epigenetics 7 (6), 542-550, 2012 | 84 | 2012 |
| KAT6B is a tumor suppressor histone H3 lysine 23 acetyltransferase undergoing genomic loss in small cell lung cancer L Simó-Riudalbas, M Pérez-Salvia, F Setien, A Villanueva, C Moutinho, ... Cancer research 75 (18), 3936-3945, 2015 | 80 | 2015 |
| DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia HJ Ferreira, H Heyn, M Vizoso, C Moutinho, E Vidal, A Gomez, ... Oncogene 35 (23), 3079-3082, 2016 | 67 | 2016 |
| Cancer genomics identifies disrupted epigenetic genes L Simo-Riudalbas, M Esteller Human genetics 133, 713-725, 2014 | 54 | 2014 |
| DNMT3B gene amplification predicts resistance to DNA demethylating drugs L Simó‐Riudalbas, SA Melo, M Esteller Genes, Chromosomes and Cancer 50 (7), 527-534, 2011 | 46 | 2011 |
| Genome-wide DNA methylation analysis identifies novel hypomethylated non-pericentromeric genes with potential clinical implications in ICF syndrome L Simo-Riudalbas, A Diaz-Lagares, S Gatto, M Gagliardi, AB Crujeiras, ... PloS one 10 (7), e0132517, 2015 | 37 | 2015 |
| Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer M Pérez-Salvia, L Simó-Riudalbas, P Llinàs-Arias, L Roa, F Setien, ... Oncotarget 8 (31), 51621, 2017 | 30 | 2017 |
| The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer AI Kraemer, C Chong, F Huber, HS Pak, BJ Stevenson, M Müller, ... Nature cancer 4 (5), 608-628, 2023 | 20 | 2023 |
| Erratum: gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis C Anadon, S Guil, L Simo-Riudalbas, C Moutinho, F Setien, ... Oncogene 35 (33), 4422, 2016 | 12 | 2016 |
| Barcelona conference on epigenetics and cancer: 50 years of histone acetylation M Perez-Salvia, L Simó-Riudalbas, J Ausió, M Esteller Epigenetics 10 (5), 446-451, 2015 | 12 | 2015 |
| Transposon-activated POU5F1B promotes colorectal cancer growth and metastasis L Simó-Riudalbas, S Offner, E Planet, J Duc, L Abrami, S Dind, A Coudray, ... Nature Communications 13 (1), 4913, 2022 | 9 | 2022 |
| Erratum: DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia HJ Ferreira, H Heyn, M Vizoso, C Moutinho, E Vidal, A Gomez, ... Oncogene 36 (29), 4233, 2017 | 7 | 2017 |
| The KZFP/KAP1 system controls transposable elements-embedded regulatory sequences in adult T cells F Marzetta, L Simó-Riudalbas, J Duc, E Planet, S Verp, P Turelli, D Trono bioRxiv, 523597, 2019 | 3 | 2019 |
| Transposable element-driven transcripts as new cancer biomarkers L Simo-Riudalbas, E Planet, J Duc, D Trono Human Gene Therapy 29 (12), A52-A52, 2018 | 1 | 2018 |
| Correction for Melo et al., Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing SRC Melo, A Villanueva Garatachea, C Moutinho, V Davalos, R Spizzo, ... Proceedings of the National Academy of Sciences of the United States of …, 2017 | 1 | 2017 |
